1-benzylpiperidine has been researched along with Acute Confusional Senile Dementia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, P; Shrivastava, SK; Singh, SP; Singh, SS; Tripathi, A; Tripathi, PN | 1 |
| Akbarzadeh, T; Edraki, N; Felegari, P; Firuzi, O; Hariri, R; Iraji, A; Mahdavi, M; Mirfazli, SS; Rastegari, A; Saeedi, M | 1 |
| Campillo, NE; Carvalho, I; de Andrade, P; Gonçalves Nunes, PS; Hojo, ETS; Magadán, CR; Mantoani, SP; Martínez, A; Pérez, C; Xavier, DJ | 1 |
| Krishnamurthy, S; Prajapati, SK; Seth, A; Sharma, P; Shrivastava, SK; Srivastava, P; Tiwari, V; Tripathi, A; Tripathi, MK; Tripathi, PN | 1 |
| Cordier, W; Johan van der Westhuizen, C; Nell, M; Panayides, JL; Riley, DL; Stander, A; Steenkamp, V; van Greunen, DG | 1 |
| Ismaïli, L; Iutzeler, A; Luzet, V; Pudlo, M; Refouvelet, B; Tomassoli, I | 1 |
| Estrada, M; Herrera-Arozamena, C; Morales-García, JA; Pérez, C; Pérez-Castillo, A; Rodríguez-Franco, MI; Romero, A; Viña, D | 1 |
| Chioua, M; Estrada, M; Iriepa, I; Marco-Contelles, J; Moraleda, I; Pérez, C; Rodríguez-Franco, MI; Samadi, A | 1 |
8 other study(ies) available for 1-benzylpiperidine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Novel Molecular Hybrids of
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Brain; Drug Design; Molecular Docking Simulation; Oxadiazoles; Piperidines; Rats; Structure-Activity Relationship | 2019 |
Novel N-benzylpiperidine derivatives of 5-arylisoxazole-3-carboxamides as anti-Alzheimer's agents.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Isoxazoles; Molecular Docking Simulation; Molecular Structure; Neuroprotective Agents; PC12 Cells; Piperidines; Rats; Structure-Activity Relationship | 2021 |
Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease.
Topics: Alzheimer Disease; Butyrylcholinesterase; Cholinesterase Inhibitors; Click Chemistry; Drug Design; Drug Discovery; Humans; Molecular Docking Simulation; Piperidines; Structure-Activity Relationship | 2019 |
Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Blood-Brain Barrier; Cell Line, Tumor; Cholinesterase Inhibitors; Cognitive Dysfunction; Drug Design; Humans; Mice; Piperidines; Protein Aggregation, Pathological; Structure-Activity Relationship | 2019 |
Novel N-benzylpiperidine carboxamide derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Eels; Horses; Humans; Models, Molecular; Molecular Structure; Piperidines; Structure-Activity Relationship | 2019 |
Quinolone-benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Antioxidants; Binding Sites; Catalytic Domain; Cholinesterase Inhibitors; Humans; Molecular Docking Simulation; Piperidines; Quinolones; Structure-Activity Relationship | 2014 |
New cinnamic - N-benzylpiperidine and cinnamic - N,N-dibenzyl(N-methyl)amine hybrids as Alzheimer-directed multitarget drugs with antioxidant, cholinergic, neuroprotective and neurogenic properties.
Topics: Alzheimer Disease; Amines; Animals; Antioxidants; Cell Line, Tumor; Cholinesterases; Drug Design; Humans; Male; Mice; Molecular Targeted Therapy; Monoamine Oxidase; Neuroprotective Agents; Piperidines | 2016 |
Pyridonepezils, new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease: synthesis, biological assessment, and molecular modeling.
Topics: Acetylcholinesterase; Alzheimer Disease; Aminopyridines; Binding Sites; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Donepezil; Enzyme Assays; Humans; Indans; Models, Biological; Models, Molecular; Nitriles; Permeability; Piperidines; Protein Binding; Pyridines; Structure-Activity Relationship | 2012 |